N Heller1, R Tejpaul1, F Isensee2, T Benidir3, M Hofmann3, P Blake4, Z Rengal4, K Moore5, N Sathianathen6, A Kalapara6, J Rosenberg4, S Peterson7, E Walczak4, A Kutikov8, R G Uzzo8, D A Palacios3, E M Remer3,9, S C Campbell3, N Papanikolopoulos1, Christopher J Weight3. 1. Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota. 2. German Cancer Research Center (DKFZ) Heidelberg, University of Heidelberg, Heidelberg, Germany. 3. Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. 4. University of Minnesota School of Medicine, Minneapolis, Minnesota. 5. Carleton College, Northfield, Minnesota. 6. Department of Urology, University of Melbourne, Melbourne, Australia. 7. Brigham Young University, Provo, Utah. 8. Urology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 9. Department of Diagnostic Radiology, Imaging Institute Cleveland Clinic, Cleveland, Ohio.
Abstract
PURPOSE: We sought to automate R.E.N.A.L. (for radius, exophytic/endophytic, nearness of tumor to collecting system, anterior/posterior, location relative to polar line) nephrometry scoring of preoperative computerized tomography scans and create an artificial intelligence-generated score (AI-score). Subsequently, we aimed to evaluate its ability to predict meaningful oncologic and perioperative outcomes as compared to expert human-generated nephrometry scores (H-scores). MATERIALS AND METHODS: A total of 300 patients with preoperative computerized tomography were identified from a cohort of 544 consecutive patients undergoing surgical extirpation for suspected renal cancer at a single institution. A deep neural network approach was used to automatically segment kidneys and tumors, and geometric algorithms were developed to estimate components of R.E.N.A.L. nephrometry score. Tumors were independently scored by medical personnel blinded to AI-scores. AI- and H-score agreement was assessed using Lin's concordance correlation and their predictive abilities for both oncologic and perioperative outcomes were assessed using areas under the curve. RESULTS: Median age was 60 years (IQE 51-68), and 40% were female. Median tumor size was 4.2 cm and 91.3% had malignant tumors, including 27%, 37% and 24% with high stage, grade and necrosis, respectively. There was significant agreement between H-scores and AI-scores (Lin's ⍴=0.59). Both AI- and H-scores similarly predicted meaningful oncologic outcomes (p <0.001) including presence of malignancy, necrosis, and high-grade and -stage disease (p <0.003). They also predicted surgical approach (p <0.004) and specific perioperative outcomes (p <0.05). CONCLUSIONS: Fully automated AI-generated R.E.N.A.L. scores are comparable to human-generated R.E.N.A.L. scores and predict a wide variety of meaningful patient-centered outcomes. This unambiguous artificial intelligence-based scoring is intended to facilitate wider adoption of the R.E.N.A.L. score.
PURPOSE: We sought to automate R.E.N.A.L. (for radius, exophytic/endophytic, nearness of tumor to collecting system, anterior/posterior, location relative to polar line) nephrometry scoring of preoperative computerized tomography scans and create an artificial intelligence-generated score (AI-score). Subsequently, we aimed to evaluate its ability to predict meaningful oncologic and perioperative outcomes as compared to expert human-generated nephrometry scores (H-scores). MATERIALS AND METHODS: A total of 300 patients with preoperative computerized tomography were identified from a cohort of 544 consecutive patients undergoing surgical extirpation for suspected renal cancer at a single institution. A deep neural network approach was used to automatically segment kidneys and tumors, and geometric algorithms were developed to estimate components of R.E.N.A.L. nephrometry score. Tumors were independently scored by medical personnel blinded to AI-scores. AI- and H-score agreement was assessed using Lin's concordance correlation and their predictive abilities for both oncologic and perioperative outcomes were assessed using areas under the curve. RESULTS: Median age was 60 years (IQE 51-68), and 40% were female. Median tumor size was 4.2 cm and 91.3% had malignant tumors, including 27%, 37% and 24% with high stage, grade and necrosis, respectively. There was significant agreement between H-scores and AI-scores (Lin's ⍴=0.59). Both AI- and H-scores similarly predicted meaningful oncologic outcomes (p <0.001) including presence of malignancy, necrosis, and high-grade and -stage disease (p <0.003). They also predicted surgical approach (p <0.004) and specific perioperative outcomes (p <0.05). CONCLUSIONS: Fully automated AI-generated R.E.N.A.L. scores are comparable to human-generated R.E.N.A.L. scores and predict a wide variety of meaningful patient-centered outcomes. This unambiguous artificial intelligence-based scoring is intended to facilitate wider adoption of the R.E.N.A.L. score.
Authors: Massimiliano Spaliviero; Bing Ying Poon; Omer Aras; Pier Luigi Di Paolo; Giuliano B Guglielmetti; Christian Z Coleman; Christoph A Karlo; Melanie L Bernstein; Daniel D Sjoberg; Paul Russo; Karim A Touijer; Oguz Akin; Jonathan A Coleman Journal: World J Urol Date: 2014-08-24 Impact factor: 4.226
Authors: Nidhi Sharma; Zhiling Zhang; Maria C Mir; Toshio Takagi; Jennifer Bullen; Steven C Campbell; Erick M Remer Journal: Urology Date: 2015-07 Impact factor: 2.649
Authors: Alexander Kutikov; Marc C Smaldone; Brian L Egleston; Brandon J Manley; Daniel J Canter; Jay Simhan; Stephen A Boorjian; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo Journal: Eur Urol Date: 2011-04-01 Impact factor: 20.096
Authors: Titus Josef Brinker; Achim Hekler; Jochen Sven Utikal; Niels Grabe; Dirk Schadendorf; Joachim Klode; Carola Berking; Theresa Steeb; Alexander H Enk; Christof von Kalle Journal: J Med Internet Res Date: 2018-10-17 Impact factor: 5.428
Authors: Nityam Rathi; Yosuke Yasuda; Worapat Attawettayanon; Diego A Palacios; Yunlin Ye; Jianbo Li; Christopher Weight; Mohammed Eltemamy; Tarik Benidir; Robert Abouassaly; Steven C Campbell Journal: Int Urol Nephrol Date: 2022-07-17 Impact factor: 2.266